Clinicopathologic significance of S100A4 expression in osteosarcoma

European Review for Medical and Pharmacological Sciences

Volumn 18, Issue 6, 2014, Pages 833-839

  Cao, C M ^a   Yang, F X ^b   Wang, P L ^c   Yang, Q X ^a   Sun, X R ^d  

^a JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b WEIFANG PEOPLE'S HOSPITAL   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d Center of Hospital of Women and Children of Qingdao City   (China)

Author keywords

Immunohistochemity; Metastasis; Osteosarcoma; Prognosis; S100A4

Indexed keywords

ANTINEOPLASTIC AGENT; CALVASCULIN; PROTEIN S 100; S100A4 PROTEIN, HUMAN;

ADOLESCENT; ARTICLE; BONE TISSUE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OSTEOSARCOMA; OVERALL SURVIVAL; PROTEIN EXPRESSION; TREATMENT RESPONSE; TUMOR VOLUME; BONE NEOPLASMS; GENE EXPRESSION; GENETICS; KAPLAN MEIER METHOD; PATHOLOGY; PROCEDURES; PROGNOSIS; SURVIVAL RATE;

ADOLESCENT; BONE NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; OSTEOSARCOMA; PROGNOSIS; S100 PROTEINS; SURVIVAL RATE;

EID: 84902113054     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. ZWAGA T, BOVEE JV, KROON HM. Osteosarcoma of the femur with skip, lymph node, and lung metastases. Radiographics 2008; 28: 277-283.
2. DAVIES BR, DAVIES MP, GIBBS FE, BARRACLOUGH R, RUDLAND PS. Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calciumbinding protein, but not with the oncogene EJ-ras-1. Oncogene 1993; 8: 999-1008.
3. MAELANDSMO GM, HOVIG E, SKREDE M, ENGEBRAATEN O, FLORENES VA, MYKLEBOST O, GRIGORIAN M, LUKANIDIN E, SCANLON KJ, FODSTAD O. Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme. Cancer Res 1996; 56: 5490-5498.
4. MAELANDSMO GM, HOVIG E, SKREDE M, ENGEBRAATEN O, FLORENES VA, MYKLEBOST O, GRIGORIAN M, LUKANIDIN E, SCANLON KJ, FODSTAD O. Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme. Cancer Res 1996; 56: 5490-5498.
5. TAKENAGA K, NAKAMURA Y, SAKIYAMA S. Expression of antisense RNA to S100A4 gene encoding an S100-related calcium-binding protein suppresses metastatic potential of high-metastatic Lewis lung carcinoma cells. Oncogene 1997; 14: 331-337.
6. RUDLAND PS, PLATT-HIGGINS A, RENSHAW C, WEST CR, WINSTANLEY JH,ROBERTSON L, BARRACLOUGH R. Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. Cancer Res 2000; 60: 1595-1603.
7. CHO YG, NAM SW, KIM TY, KIM YS, KIM CJ, PARK JY, LEE JH, KIM HS, LEE JW, PARK CH, SONG YH, LEE SH, YOO NJ, LEE JY, PARK WS. Overexpression of S100A4 is closely related to the aggressiveness of gastric cancer. APMIS 2003; 111: 539-545.
8. LIU Y, TANG W, WANG J, XIE L, LI T, HE Y, QIN X, LI S. Clinicopathological and prognostic significance of S100A4 overexpression in colorectal cancer: a meta-analysis. Diagn Pathol 2013; 8: 181.
9. BANDIERA A, MELLONI G, FRESCHI M, GIOVANARDI M, CARRETTA A, BORRI A, CIRIACO P, ZANNINI P. Prognostic factors and analysis of S100a4 protein in resected pulmonary metastases from renal cell carcinoma. World J Surg 2009; 33: 1414-1420.
10. ROH J, KNIGHT S, CHUNG JY, EO SH, GOGGINS M, KIM J, CHO H, YU E, HONG SM. S100A4 expression is aprognostic indicator in small intestine adenocarcinoma. J Clin Pathol 2014; 67: 216-221.
11. ZHANG K, ZHANG M, ZHAO H, YAN B, ZHANG D, LIANG J. S100A4 regulates motility and invasiveness of human esophageal squamous cell carcinoma through modulating the AKT/Slug signal pathway. Dis Esophagus 2012; 25: 731-739.
12. MAZZUCCHELLI L. Protein S100A4: too long overlooked by pathologists? Am J Pathol 2002; 160: 7-13.
13. HELFMAN DM, KIM EJ, LUKANIDIN E, GRIGORIAN M. The metastasis associated protein S100A4: role in tumour progression and metastasis. Br J Cancer 2005; 92: 1955-1958.
14. LIU Z, LIU H, PAN H, DU Q, LIANG J. Clinicopathological significance of S100A4 expression in human hepatocellular carcinoma. J Int Med Res 2013; 41: 457-462.
15. BJØRNLAND K, WINBERG JO, ODEGAARD OT, HOVIG E, LOENNECHEN T, AASEN AO, FODSTAD O, MAELANDSMO GM. S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme. Cancer Res 1999; 59: 4702-4708.
16. MATHISEN B, LINDSTAD RI, HANSEN J, EL-GEWELY SA, MAELANDSMO GM, HOVIG E, FODSTAD O, LOENNECHEN T, WINBERG JO. S100A4 regulates membrane induced activation of matrix metalloproteinasE2 in osteosarcoma cells. Clin Exp Metastasis 2003; 20: 701-711.
17. ZHANG G, LI M, JIN J, BAI Y, YANG C. Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinasE9. Asian Pac J Cancer Prev 2011; 12: 2075-2080.
18. MA X, YANG Y, WANG Y, AN G, LV G. Small interfering RNA-directed knockdown of S100A4 decreases proliferation and invasiveness of osteosarcoma cells. Cancer Lett 2010; 299: 171-181.
19. FUJIWARA M, KASHIMA TG, KUNITA A, KII I, KOMURA D, GRIGORIADIS AE, KUDO A, ABURATANI H, FUKAYAMA M. Stable knockdown of S100A4 suppresses cell migration and metastasis of osteosarcoma. Tumour Biol 2011; 32: 611-622.
20. SOBIN LH, WITTEKIND C. UICC-TNM Classificaton of Malignant Tumors. New York: Wiley, 2002; pp. 93- 96.
21. GLINKA Y, MOHAMMED N, SUBRAMANIAM V, JOTHY S, PRUD'HOMME GJ. Neuropilin-1 is expressed by breast cancer stem-like cells and is linked to NFKb activation and tumor sphere formation. Biochem Biophys Res Commun 2012; 425: 775-780.
22. LING Z, LI R. Clinicopathological and prognostic value of S100A4 expression in gastric cancer: a meta-analysis. Int J Biol Markers 2013 Nov 18:0. [Epub ahead of print]
23. RUYS AT, GROOT KOERKAMP B, WIGGERS JK, KLÜMPEN HJ, TEN KATE FJ, VAN GULIK TM. Prognostic biomarkers in patients with resected cholangiocarcinoma: a systematic review and meta-analysis. Ann Surg Oncol 2014; 21: 487-500.
24. JIN L, SHEN Q, DING S, JIANG W, JIANG L, ZHU X. Immunohistochemical expression of Annexin A2 and S100A proteins in patients with bulky stage IB-IIA cervical cancer treated with neoadjuvant chemotherapy.Gynecol Oncol 2012; 126: 140-146.
25. MENCÍA N, SELGA E, RICO I, DE ALMAGRO MC, VILLALOBOS X, RAMIREZ S, ADAN J, HERNÁNDEZ JL, NOÉ V, CIUDAD CJ. Overexpression of S100A4 in human cancer cell lines resistant to methotrexate. BMC Cancer 2010; 10: 250.